Amedisys Reports Third Quarter 2019 Financial Results and Updates 2019 Guidance
Amedisys Inc (AMED)
Last amedisys inc earnings: 2/18 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amedisys.com
Company Research
Source: GlobeNewswire
BATON ROUGE, La., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2019. Three Month Periods Ended September 30, 2019 and 2018 Net service revenue increased $77.3 million to $494.6 million compared to $417.3 million in 2018.Net income attributable to Amedisys, Inc. of $34.1 million compared to $31.4 million in 2018.Net income attributable to Amedisys, Inc. per diluted share of $1.03 compared to $0.96 in 2018. Adjusted Quarterly Results* Adjusted EBITDA of $56.8 million compared to $45.3 million in 2018.Adjusted net service revenue of $494.6 million compared to $417.3 million in 2018.Adjusted net income attributable to Amedisys, Inc. of $37.9 million compared to $30.9 million in 2018.Adjusted net income attributable to Amedisys, Inc. per diluted share of $1.15 compared to $0.95 in 2018. Nine Month Periods Ended September 30, 2019 and 2018 Net service revenue increased
Show less
Read more
Impact Snapshot
Event Time:
AMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMED alerts
High impacting Amedisys Inc news events
Weekly update
A roundup of the hottest topics
AMED
News
- Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise [Yahoo! Finance]Yahoo! Finance
- Amedisys, Inc. (NASDAQ: AMED) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $101.00 price target on the stock.MarketBeat
- Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]Yahoo! Finance
- Amedisys Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
AMED
Earnings
- 2/21/24 - Miss
AMED
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/25/24 - Form 10-Q
- 4/24/24 - Form 8-K
- AMED's page on the SEC website